Galapagos NV ADR (GLPG) - Stock Price & Dividends
Exchange: USA Stocks • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: US36315X1019
Galapagos NV, listed asGLPG on NASDAQ, is an innovative biopharmaceutical company based in Mechelen, Belgium. Since its establishment in 1999, the company has been dedicated to discovering, developing, and bringing to market a range of medicines to address critical medical needs.
Among its notable pipeline productsis filgotinib, which holds promise as a JAK1 inhibitor undergoing clinical trials for conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. Additionally, the company's pipeline includes GLPG3667, which has completed Phase 1b trials, alongside pioneering products like GLPG5101 and GLPG5201 - advanced CD19 CAR-T therapies produced at the point-of-care, currently undergoing Phase I/II trials for relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Galapagos NV has forged strategic collaborations with industry leaders like Gilead Sciences, Inc., AbbVie S.à r.l., and Novartis Pharma AG to further enhance the development and commercialization of its groundbreaking therapeutics. For more information on Galapagos NV and its transformative work in the biopharmaceutical realm, visit their website: https://www.glpg.com.
Drawdown (Underwater) Chart
GLPG Stock Overview
| Market Cap in USD | 1,914m |
| Sector | Healthcare |
| Industry | Biotechnology |
| GiC SubIndustry | Biotechnology |
| TER | 0.00% |
| IPO / Inception | 2005-05-06 |
GLPG Stock Ratings
| Growth 5y | -6.24 |
| Fundamental | -48.7 |
| Dividend | - |
| Rel. Performance vs Sector | -3.47 |
| Analysts | 3.29/5 |
| Fair Price Momentum | 21.22 USD |
| Fair Price DCF | - |
GLPG Dividends
| Yield 12m | 0.00% |
| Yield on Cost 5y | 0.00% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 0.0% |
GLPG Growth Ratios
| Growth 12m | -26.26% |
| Growth Correlation 12m | -50% |
| Growth Correlation 3m | -84% |
| CAGR 5y | -23.99% |
| Sharpe Ratio 12m | -1.23 |
| Alpha vs SP500 12m | -50.06 |
| Beta vs SP500 5y weekly | 0.99 |
| ValueRay RSI | 19.02 |
| Volatility GJR Garch 1y | 25.22% |
| Price / SMA 50 | -13.43% |
| Price / SMA 200 | -21.83% |
| Current Volume | 75.4k |
| Average Volume 20d | 142.4k |
External Links for GLPG Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 28.76 with a total of 75,390 shares traded.
Over the past week, the price has changed by -1.10%, over one month by -12.08%, over three months by -24.64% and over the past year by -26.54%.
According to ValueRays Forecast Model, GLPG Galapagos NV ADR will be worth about 23.7 in April 2025. The stock is currently trading at 28.76. This means that the stock has a potential downside of -17.66%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 41.9 | 45.7 |
| Analysts Target Price | 46.9 | 63.0 |
| ValueRay Target Price | 23.7 | -17.7 |